Mode
Text Size
Log in / Sign up

Meta-analysis finds dietary fibre reduces metabolic endotoxemia and inflammatory cytokines

Meta-analysis finds dietary fibre reduces metabolic endotoxemia and inflammatory cytokines
Photo by Logan Voss / Unsplash
Key Takeaway
Consider dietary fibre supplementation cautiously for reducing metabolic endotoxemia, given high heterogeneity and limited evidence.

This systematic review and meta-analysis pooled data from 773 participants to evaluate the effect of dietary fibre (DF) supplementation on metabolic endotoxemia (ME) and inflammatory markers. The primary outcome was ME, assessed via serum lipopolysaccharide levels, and secondary outcomes included TNF-α, IL-10, lipopolysaccharide-binding protein, C-reactive protein, IL-6, HDL, and LDL.

DF supplementation significantly decreased serum lipopolysaccharide levels (p < 0.00001, I² = 97%) and TNF-α levels (p < 0.02, I² = 90%), and significantly increased IL-10 levels (p < 0.02, I² = 85%). However, no significant effects were observed on lipopolysaccharide-binding protein, C-reactive protein, IL-6, HDL, or LDL.

Notable limitations include very high heterogeneity for the significant outcomes (I² ≥ 85%), which reduces confidence in the pooled estimates. Additionally, the comparator, follow-up duration, and adverse events were not reported, limiting clinical applicability. The authors suggest DF supplementation may help ameliorate ME and inflammatory cytokines, potentially preventing chronic inflammation-related diseases, but the evidence is preliminary.

Clinicians should interpret these findings cautiously due to high heterogeneity and incomplete reporting. Further well-designed trials with standardized protocols are needed before recommending DF supplementation specifically for reducing endotoxemia.

Study Details

Study typeMeta analysis
Sample sizen = 773
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
The objective of this systematic review and meta-analysis was to evaluate the impact of dietary fibre (DF) supplementation on metabolic endotoxemia (ME). A comprehensive search of multiple databases was conducted to identify relevant clinical trials. Selected trials were systematically reviewed, and a meta-analysis was performed using a random-effects model. The comprehensive database search retrieved 732 records; of these, 15 randomised controlled trials involving a total of 773 participants fulfilled the eligibility criteria and were subsequently included in the systematic review and meta-analysis. Supplementation with DF significantly decreased serum lipopolysaccharide levels ( < 0.00001, I = 97%). TNF-α levels also decreased significantly ( < 0.02, I = 90%), while IL-10 levels increased ( < 0.02, I = 85%). DF supplementation did not significantly affect lipopolysaccharide-binding protein, C-reactive protein, IL-6, HDL, or LDL levels. The pooled evidence provides evidence to support the use of DF supplementation in ameliorating ME and inflammatory cytokines which could prevent chronic inflammation-related diseases.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.